Egg Allergy and Influenza Vaccination

pdfASCIA PCC Egg Allergy and Influenza Vaccination120.38 KB

People with egg allergy may be safely vaccinated with the influenza (flu) vaccine. Vaccination is an important method to reduce the risk of developing infectious diseases, including influenza, which is a major cause of illness and deaths worldwide. Notification and hospitalisation rates for influenza infections are highest in children up to five years of age, which is also the age group most affected by egg allergy.

Influenza vaccines and egg protein

The current influenza vaccines distributed in Australia and New Zealand are derived from influenza virus, and grown in hen’s egg. Once purified, the amount of residual egg ovalbumin present in each vaccine dose is usually less than 1 microgram. This is substantially less than the amount of egg protein that is likely to trigger reactions in people with egg allergy, which is estimated at 130 micrograms taken orally.

Safety of influenza vaccines in individuals with egg allergy

Several published reviews, guidelines and reports suggest no increased risk of anaphylaxis associated with influenza vaccination of people with egg-allergy. A 2012 review of published studies included 4172 egg-allergic patients (513 with a history of a severe egg allergy) with no cases of anaphylaxis occurring after receiving an inactivated influenza vaccine. Further studies have confirmed these results.

Severe allergic reactions to vaccination are very rare

The risk of a severe allergic reaction (anaphylaxis) to inactivated influenza vaccine is similar to other vaccines, and estimated at 1.35 per million doses.

Minor short lived side effects from vaccination are common

Injection site reactions (such as local pain, redness and swelling), fever, muscle aches, irritability or worsened eczema a day after vaccination are common side effects. They indicate the start of an immune response, not vaccine allergy.

Recommendations

There is no evidence that having egg allergy increases the risk of having an allergic reaction to the currently available influenza vaccines. Therefore, people with an egg allergy can receive an influenza vaccine in facilities with staff able to recognise and treat suspected anaphylaxis, which includes administration of adrenaline (epinephrine). Observations should occur for 15-20 minutes after vaccination.

Further advice and variance from product information

This advice is consistent with Australian and New Zealand immunisation guidelines and has been adapted from ASCIA Guidelines for vaccination of the egg-allergic individual, which are available on the ASCIA website www.allergy.org.au/hp/papers/vaccination-of-the-egg-allergic-individual

This advice varies to the vaccine product information, which indicates that egg allergy is a contraindication to influenza vaccination and lists egg allergy as a special warning or precaution. This means that even though the likelihood of having an allergic reaction is very low, people with egg allergy must be in a medical facility when vaccinated.

© ASCIA 2019

ASCIA is the peak professional body of clinical immunology/allergy specialists in Australia and New Zealand.

ASCIA resources are based on published literature and expert review, however, they are not intended to replace medical advice. The content of ASCIA resources is not influenced by any commercial organisations.

For more information go to www.allergy.org.au

To donate to immunology/allergy research go to www.allergyimmunology.org.au

Mod ASCIA Member
Donate to AIFA
go to NAS website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Accreditiation

healthdirect
This website is certified by Health On the Net Foundation. Click to verify.This site complies with the HONcode standard for trustworthy health information.Verify here.